Outcomes | Study sample | With SAHE | Without SAHE | P Value |
---|---|---|---|---|
( N = 931) | ( N = 121) | ( N = 810) | ||
At 1 month | ||||
mRS scorea | 4 (1–4) | 4 (4–6) | 3(1–4) | < 0.0001 |
Deathb | 129 (13.9%) | 40 (33.1%) | 89 (11.0%) | < 0.0001 |
Severe disabilityb | 348 (43.4%) | 52 (64.2%) | 296 (41.1%) | < 0.0001 |
Death or severe disabilityb | 477 (51.2%) | 92 (76.0%) | 385 (47.5%) | < 0.0001 |
At 3 months | ||||
mRS scorea | 3 (1–4) | 4 (3–6) | 3(1–4) | < 0.0001 |
Death b | 143 (15.4%) | 43 (35.5%) | 100 (12.4%) | < 0.0001 |
Severe disabilityb | 223 (28.7%) | 41 (52.6%) | 182 (25.6%) | < 0.0001 |
Death or severe disabilityb | 366 (39.4%) | 84 (69.4%) | 282 (34.9%) | < 0.0001 |
At 1 year | ||||
mRS scorea | 3 (1–4) | 5 (3–6) | 2(1–4) | < 0.0001 |
Deathb | 178 (19.1%) | 52 (43.0%) | 126 (15.6%) | < 0.0001 |
Severe disabilityb | 112 (14.9%) | 22 (31.9%) | 90 (13.2%) | < 0.0001 |
Death or severe disabilityb | 290 (31.2%) | 74 (61.2%) | 216 (26.7%) | < 0.0001 |